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Apoptosis is a form of programmed cell death common to metazoan species. BH3-only 
proteins can be thought of as ‘linchpins’ in the apoptotic cell death pathway. This is because 
of their ability to respond to a variety of cell stress signals and to promote apoptosis by 
interacting with both pro- and anti-apoptotic members of the BCL-2 protein family, making 
them master regulators of apoptosis. Apart from the short BH3 motif found in BCL-2 
homologs, there are eight canonical human BH3-only proteins that share no amino acid 
sequence similarity with other members of the BCL-2 family or with each other. The 
development of chemical or peptide mimetics of the BH3 motif to promote apoptotic cell 
death of infected or transformed cells as drugs against viruses, parasites like schistosomes 
as well as against cancer has become an important goal for both pharmaceutical industries 
and in academic settings (Shamas-Din, Brahmbhatt, Leber, & Andrews, 2011). However, 
because of the absence of a ‘signature sequence’ that rigorously defines the BH3 motif, it 
has not been possible to systematically screen for BH3-only proteins in the proteome. BH3-
only proteins function by either neutralizing anti-apoptotic BCL-2 proteins or directly 
activating the pro-apoptotic BCL-2 proteins. Th BH3 motif can be considered as bearing 
Short Linear Motifs (SLiMs) that is 8-12 amino acids long with two ‘hot-spot’ residues: 
Asp (D) and Leu (L), which are essential for binding to the hydrophobic cleft of BCL-2 
family member proteins (Aouacheria, Combet, Tompa, & Hardwick, 2015). This thesis 
project focuses on 10 candidate novel BH3-only proteins that were identified by Dr. Abdel 
Aouacheria and his colleagues using proprietary computational methods to search the 




wild type (WT) as well as mutants (M) that have point mutations in the two hotspot 
residues, intended to abolish their binding activity to the hydrophobic groove of members 
of the BCL-2 family, were provided from Dr. Abdel Aouacheria.  
These candidate novel BH3-only proteins stem from diverse non-mammalian organisms 
including parasites and bacteria. Candidate BH3-only proteins were tested to determine if 
they have any pro-death function when expressed in mammalian cells. Three of the ten 
proteins were cytotoxic and localized to mitochondria, similar to many mammalian 
apoptosis regulators. Importantly, this cytotoxicity was reduced by the hot-spot mutations, 
despite wild type and mutant proteins being expressed at similar levels. These candidates 
were also tested to determine if their cytotoxicity could be inhibited by their putative 
mammalian binding partners, namely the anti-apoptotic BCL-2 family proteins BCL-xL 
and BCL-W. I found that both BCL-xL and BCL-W could rescue mammalian cells from 
the cytotoxic activity of the three killer BH3-only proteins, implying a functional 
interaction. The remaining seven non-toxic candidate BH3-containing proteins did not 
localize to mitochondria and could not be activated to induce cell death by the presence of 
the mammalian BH3-only protein tBID, which itself is highly toxic. These seven 
candidates also did not prevent anti-death proteins BCL-xL and BCL-W from rescuing 
cells from the tBID death signal. Overall, these results provide evidence for the existence 
of functional BH3 motifs in at least three of ten candidate proteins of diverse origin. These 
findings raise the possibility of evolutionary conservation of the BH3 motif as an ancient 
protein-protein interaction motif. More importantly, the algorithm opens the door to the 
possibility of accurately predicting short sequence motifs of degenerate nature but that have 
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A large body of evidence indicates that the individual cells of multi-cellular organisms can 
sense defective cellular functions and environmental effects, such as DNA damage, 
unfolded proteins, metabolic events resulting from the lack of nutrients or other 
environmental stressors or phenomena that cause the cell to activate programmed cell death 
pathways prior to cell exhaustion (Czabotar, Lessene, Strasser, & Adams, 2014). Cell death 
is an inevitable part of life, and the human body eliminates billions of cells daily, for 
example to sustain homeostatic functions and selection of functional immune cells. There 
are over a dozen different cell death pathways reported and partially characterized 
(Kroemer et al., 2009). Thus far, only three of these are sufficiently well understood at a 
molecular level to distinguish them as distinct death pathways, apoptosis, necroptosis and 
pyroptosis. This project focuses on apoptotic cell death.  
The term apoptosis was first coined in 1972 by Kerr, Wyllie and Curie in a monumental 
paper distinguishing deliberate cell death from necrosis, what was presumed at the time to 
be death by assault (no contribution from the dying cell), based on morphological changes 
and characteristics of cells (Kerr, Wyllie, & Currie, 1972). Subsequent decades of research 
have demonstrated that apoptosis is a tightly regulated process that leads to cell death 
mediated by a set of enzymes known as caspases (cysteine-aspartic proteases), caspase-3 
in particular (Elmore, 2007). Apoptosis is a highly complex and energy driven process that 
can be broadly categorized into the intrinsic (mitochondria-mediated) or extrinsic (death 
receptor-mediated) pathways (Hotchkiss, Strasser, McDunn, & Swanson, 2009) The 
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‘extrinsic’ pathway is characterized by the specific binding of ligands, for example Tumor 
Necrosis Factor-alpha (TNF), to ‘death receptors’ expressed on the surface of the plasma 
membrane, which can signal caspase-dependent cell death (Elmore, 2007). The ‘intrinsic 
pathway’ or mitochondrial apoptotic pathway on the other hand is regulated by interaction 
between the pro and anti-death members of the BCL-2 family, described below. This 
pathway can be triggered by stress such as DNA damage or even by cytokine activation, 
leading to mitochondrial outer membrane permeabilisation (MOMP) (Green & Reed, 
1998). The permeablized outer membrane then releases cytochrome c, leading to the 
formation of the apoptosome, which directly activates caspase-9 that in turn cleaves and 
activates caspase 3 to cause apoptotic cell death (Riedl & Salvesen, 2007). Dysregulation 
of the apoptotic pathway can lead to deleterious effects such as tumors or even autoimmune 
diseases (Thompson, 1995). 
The BCL-2 family of proteins 
The BCL-2 family of proteins consists of several structurally and functionally related 
proteins. The members of this protein family that regulate apoptosis consist of both pro- 
and anti-apoptotic proteins. (Cory & Adams, 2002)The founding member of this family, 
BCL-2, was first identified as a novel proto-oncogene in follicular B-cell lymphomas near 
the defining 14 (q32);18 (q21) translocation, linking the immunoglobulin heavy chain 
locus to a novel gene to alter its expression pattern (Tsujimoto, Finger, Yunis, Nowell, & 
Croce, 1984). This gene was named B cell lymphoma/leukemia-2 or BCL-2. Unexpectedly, 
BCL-2 was shown to prevent cell death as opposed to increase cell proliferation (Vaux, 
Cory, & Adams, 1988). The over-expression of BCL-2 in many cancers leads to resistance 
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to therapeutics and evasion of cell death by upregulating anti-apoptotic BCL-2 proteins is 
considered a “hallmark” of cancer (Hanahan & Weinberg, 2000). 
Contributing importantly to our understanding of human BCL-2 was the simultaneous 
discovery of the functions of CED-9 and CED-3 in the nematode C.elegans. CED-9 is the 
homolog of BCL-2 and CED-3 is the worm caspase. CED-9 was identified as the gene 
responsible for preventing developmental cell death due to CED-3 (Hengartner & Horvitz, 
1994a). This and other work from the Horvitz group identifying many other components 
of the apoptosis pathway proved to be evolutionarily conserved across different species 
and was honored with the Nobel prize in 2002 (Ellis & Horvitz, 1986; Hengartner & 
Horvitz, 1994b; Yuan & Horvitz, 1990). 
In contrast to worms, humans have several BCL-2 homologs with pro- and anti-apoptotic 
functions. These proteins share sequence and structural similarity, adopting a single alpha-
helical globular domain and lack sequence similarity to other protein families. Within the 
BCL-2 family, there are four regions of greatest similarity known as BCL-2 homology 
(BH) motifs BH1-4 (Adams & Cory, 1998; Czabotar et al., 2014; Muchmore et al., 1996). 
Based on this similarity, the BCL-2 family of proteins can be divided into two categories. 
Anti-death proteins BCL-2, BCL-xL, BCL-W, MCL-1, A1 (BFL-1 in humans) and 
BCL2L10 share all 4 BH motifs (Hanada, Aimé-Sempé, Sato, & Reed, 1995), although the 
existence and definition of the BH motif is debated(Aouacheria, de Laval, Combet, & 
Hardwick, 2013a). Pro-death proteins BAK, BAX and BOK, share three BH motifs. The 
third category of proteins often grouped with members of the BCL-2 family shares only 
one of the four BH3 motifs, the BH3, and lacks other sequence similarity with members of 
the BCL-2 family of proteins (Hanada et al., 1995). This group of proteins is known as 
 
4 
BH3-only proteins, and is often further divided into two groups depending on whether they 
directly activate BAX or BAK (BID, BIM, and PUMA), or whether they promote cell death 
by inhibiting the anti-apoptotic proteins (NOXA, BAD, BIK, HRK, BMF). The BH3 motif 
of BH3-only proteins and of pro-apoptotic BCL-2 homologs can bind into a hydrophobic 
binding cleft on anti-apoptotic BCL-2 family proteins (Aouacheria et al., 2015; Czabotar 
et al., 2014). Many of the BCL-2 homologs also possess C-terminal hydrophobic tails that 
allow them to insert into cellular membranes, particularly the mitochondria and 
endoplasmic reticulum (ER) (Gross, McDonnell, & Korsmeyer, 1999). 
The BH3-only group of proteins 
BH3-only proteins regulate cell death by binding to and influencing both the anti- and pro-
death members of the BCL-2 family of proteins (Youle & Strasser, 2008). Downstream of 
an intrinsic death signal, the pro- and anti-apoptotic BCL-2 family members interact which 
can eventually lead to oligomerization of pro-apoptotic proteins BAX and BAX, leading 
to MOMP and eventually, caspase mediated cell death(Elmore, 2007; Llambi et al., 2011). 
BH3-only proteins are usually inactive at organellar membranes unless activated at a 
transcriptional level and by post translational modifications which influence their binding 
with other members of the BCL-2 family of proteins (Huang & Strasser, 2000a).  
Based on their selective binding, BH3-only proteins are also classified as sensitizers versus 
activators(Shamas-Din et al., 2011). Depending on their sequence and structure, the 8 
canonical BH3-only proteins have differential binding to anti-apoptotic members of the 
BCL-2 family. Activators are shown to bind to BCL-2, BCL-xL, BCL-W, A1 as well as 
MCL-1, the proteins BID, BIM and PUMA fall into this category(Chen et al., 2005a). 
Sensitizers on the other hand selectively bind to MCL-1 or A1 (Letai et al., 2002). This 
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selective binding is important for BH3 mimetics (Lee et al., 2011). There are currently two 
different models for activation of BAX/BAK by BH3-only proteins (Letai et al., 2002). 
The direct activation model involves binding of activator proteins to the anti-apoptotic 
members of the BCL-2 family, thereby “sensitizing” the cells for death. The sensitizer 
BH3-only proteins can then bind to BAK/BAK, leading to MOMP, the “point of no return” 
for apoptosis (Shamas-Din et al., 2011). The indirect activation model involves competitive 
binding of BH3-only proteins to anti-apoptotic members of the BCL-2 family of proteins 
such that they either prevent binding of or displace BAK/BAX from the hydrophobic 
groove on the anti-apoptotic proteins (Kuwana et al., 2005). The free BAK and BAX can 
now oligomerize, leading to MOMP and eventually, caspase mediated cell death (Chen et 
al., 2005b).  
BH3-only proteins in homeostasis and disease 
Apart from regulation of apoptosis, BH3-only proteins and BCL-2 homologs also have 
functions in normal healthy cells prior to induction of apoptosis (Gross & Katz, 2017; 
Hardwick, Chen, & Jonas, 2012). In addition to cell death, BH3-only proteins are involved 
in other functions such as, homeostasis and DNA damage (Lomonosova & Chinnadurai, 
2008a). A disturbance in the balance between BH3-only proteins and other members of the 
BCL-2 family of proteins could lead to tumorigenesis and auto-immune 
diseases(Thompson, 1995). For example, Bouillet et al showed that progeny of Bim+/- was 
half that of wild type Bim mice (Bouillet et al., 1999). They showed that Bim-/- fetuses died 
before day 10 of the embryonic stage, this was however strain dependent and may be 
attributed to genetic background as well. Mice lacking Bim also have a two-fold increase 
in the numbers of B-lymphocytes, monocytes, granulocytes and T-lymphocytes, 
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suggesting a role in the development of the immune system as well (Bouillet et al., 1999). 
Studies have also shown that ablation of one copy of Bim leads to an increase in c-myc 
expression, which leads to formation of lymphomas (Egle, Harris, Bouillet, & Cory, 2004). 
The BH3-only protein BAD was shown to play a role in the regulation of cell cycle via 
interaction with BCL-xL(Chattopadhyay, Chiang, & Yang, 2001). Bad also acts as a 
regulator of glucose levels in pancreatic islets (Danial et al., 2003). Bmf has been shown to 
play a role in colon, lung and breast cancer(Wick et al., 1996). Hrk plays a role in gastric 
cancer(Obata et al., 2003). Bik mRNA levels are highly upregulated in human lung, 
prostrate and renal cancers (Glab, Mbogo, & Puthalakath, 2017). Puma-/- mice were shown 
to be resistant to apoptosis induced by external cytotoxic stimuli (Lomonosova & 
Chinnadurai, 2008a). It was also shown that in response to DNA-damaging agents, Puma 
is upregulated in many cancers (Han et al., 2001). Although Noxa-/- mice did not seem to 
show any detectable phenotypic developmental abnormalities, NOXA is mutated or 
silenced in diffuse large B-cell lymphomas (Mestre-Escorihuela et al., 2007).  
There has been intense interest in finding candidate novel BH3-only proteins in mammals 
as well as pathogenic organisms, such as schistosomes and leishmania to try and 
understand the functioning of their BH3 motifs and to develop BH3 mimetics as drugs 
against diseases causes by the parasites and viruses (Lee et al., 2011; Lee, Young, Lim, 
Gasser, & Fairlie, 2014; Rosenberg, 2011).  
BH3-only proteins as SLiMs 
The BH3 motif is a 9-16 amino acid long region that folds into an amphipathic alpha helix. 
This alpha helix is what binds to the hydrophobic cleft of the anti-apoptotic members of 
the BCL-2 family of proteins(Huang & Strasser, 2000b). After Sattler et al showed that the 
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BH3 motif is required for binding of BH3-only proteins to BCL-xL(Sattler et al., 1997), 
other groups showed that mutations in BH3 motif of the BH3-only proteins resulted not 
only in a loss of pro-death function but also an inability to bind other BCL-2 family 
members ((Lomonosova & Chinnadurai, 2008b; Sattler et al., 1997). The core BH3 motif 
consists of a hexameric sequence roughly defined as L-XXX-G-D where X is any amino 
acid, however, even the glycine (G) is not well conserved between the 8 canonical BH3-
only proteins (Lanave, Santamaria, & Saccone, 2004). Leucine (L) and aspartate (D) are 
the major conserved residues, referred to as ‘hotspot’ residues, which are essential for the 
binding of a BH3 alpha helix to anti-apoptotic members of the BCL-2 family. Given the 
importance of BH3-only proteins in homeostasis, development, apoptosis, cancer and other 
diseases, the need to find BH3 mimetics is growing. However, with the absence of a valid 
signature sequence confirmed by informatics standards, this is a difficult task relying 
primarily on visual inspection of protein sequences (Aouacheria, de Laval, Combet, & 
Hardwick, 2013b). Computational methods so far have failed to to reliably identify even 
the known BH3-only proteins in the proteome due to the limited sequence information 
available in this motif(Aouacheria et al., 2015; Billard, 2013).  
Other than BH3 motifs, there are many other short linear motifs, e.g. the SH3 motif, that 
are difficult to define based for similar reasons(Diella et al., 2008). Motifs like these can 
be defined as Short Linear Motifs or SLiM Eukaryotic Linear Motifs (ELMs). SLiMs and 
ELMs are primarily defined based on primary sequence determinants whereas MoRFs 
relate to the structural dynamics characteristics of BH3 peptide binding to the hydrophobic 
pocket present on the surface of Bcl-2 homologous proteins.(Aouacheria et al., 2015). 
These motifs serve as sites of protein-protein interaction or modification sites that are 
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critical for function. If we think of the BH3 motif as a SLiM, we can have better insight 
into its functional roles. Like SLiMs, BH3s are short motifs (9-16 amino acids long) 
(Lomonosova & Chinnadurai, 2008a) that are mostly found in disordered proteins 
(Aouacheria et al., 2015), as in the case of canonical BH3-only proteins (Rautureau, Day, 
& Hinds, 2010). Also like SLiMs, BH3s can be regulated post-transcriptionally (Glab et 
al., 2017). They lack sufficient sequence similarity and are 9-16 amino acids 
long(Lomonosova & Chinnadurai, 2008a). Also like SliMs, BH3s can be regulated post-
transcriptionally (Glab et al., 2017) 
The unresolved problem is that even if the BH3 motif is viewed as a SLiM, computational 
methods to find them remain elusive. (Aouacheria et al., 2013a; Tompa, Davey, Gibson, & 
Babu, 2014). 
BH3 mimetics 
BH3 mimetics are small molecules or peptides that mimic the BH3 motif and function by 
binding into the hydrophobic cleft of anti-death members of the BCL-2 family to promote 
cell death (Baell & Huang, 2002). It has been known for many years that BCL-2 family 
proteins are dysregulated in many diseases including cancer(Thomadaki & Scorilas, 2006; 
Thompson, 1995) . MCL-1 has been shown to be upregulated in acute myeloid leukemia 
(AML) and is essential for survival of these cells (Xiang et al., 2010). Pancreatic tumors 
have increased levels of BCL-xL(Sharma et al., 2005) . BCL-2 is over expressed in 
neuroblastomas and follicular lymphomas (Lamers et al., 2012). Over expression of BCL-
2 family proteins has also been shown to increase resistance to radiation and other forms 
of chemotherapy used to treat tumors (Cory, Huang, & Adams, 2003; Coultas & Strasser, 
2003; Delbridge & Strasser, 2015). Since the first solved crystal structure of BCL-xL 
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(Muchmore et al., 1996) , many labs and companies have been successful in developing 
small molecules that bind specifically to anti-apoptotic members of the BCL-2 family 
(Billard, 2013; Delbridge, Grabow, Strasser, & Vaux, 2016) . These small molecules mimic 
the alpha helical BH3-motif of BH3-only proteins and can bind to the binding pocket 
formed by folding of BH1 BH2 and BH3 motif of the anti-death proteins (Billard, 2013). 
Many in silico and in vitro screens are being performed to find more mimetics (Billard, 
2013; Burrer, Foight, Keating, & Chan, 2016; Lomonosova & Chinnadurai, 2008a) The 
selective binding of BH3-only proteins to anti-death proteins is a key requirement in 
developing these mimetics(Chen et al., 2005a). Previously characterized mimetics were 
path leaders for understanding how BH3 mimetics work(Billard, 2013). (Billard, 2013). 
Obatoclax was suggested to be a BH3 mimetic, however, it binds to all five anti-death 
proteins but with low affinity, and may instead be non-specific as it has similar killing 
activity in both BAX/BAK double knockout cells as well as wild type cells makes its use 
as a mimetic questionable (Vogler et al., 2009). ABT-737 and its orally bioavailable form 
ABT-263 have a higher affinity for BCL-xL, BCL-2 and BCL-W but does not bind 
appreciably to MCL-1 (Billard, 2013; van Delft et al., 2006). Venetoclax (ABT 199), which 
was recently approved by the FDA, has high affinity only for BCL-2 and has 200 times 
lower affinity for BCL-xL (Roberts et al., 2016). S63845, is a new small molecule inhibitor 
that is highly selective for MCL-1, and induces BAX/BAK-dependent killing both in vitro 
and in vivo in protection against cancers with upregulated levels of MCL-1(Kotschy et al., 
2016). There are a number of other compounds in clinical trials(Billard, 2013), thus BH3 
mimetics and BH3 profiling are important for understanding the BH3 motif and will only 






Material and methods 
Plasmid constructs 
N-terminal GFP-tagged full-length constructs of ten candidate BH3-only proteins and their 
mutants in pEGFP-c1 vectors were provided by Dr. Abdel Aouacheria, Université 
de Montpellier, France. Plasmids expressing tBID, BCL-W, BCL-xL and dominant 
negative caspase-9 were all generated by current or previous members of the lab in SG5 
vectors. 
Cell Culture  
HeLa cervical cancer cells (ATCC® CCL-2) were grown in Dulbecco’s Modified Eagle’s 
medium (DMEM) (Gibco®) supplemented with 10% FBS, 1U Penicillin/1 µg 
Streptomycin (Invitrogen®) and 2 mM L-glutamine. Cells were incubated at 37 °C and 5% 
CO2 in a humidified chamber. 
Immunostaining and microscopy 
Cells were seeded in 24 well plates (353043, Falcon®) on coverslips (Fisher®) at a density 
of ~4 x 10^4 cells per well. The next day, cells were transfected with 175 ng of total plasmid 
using 1.5 µl of Lipofectamine 2000 (Invitrogen®) and 50 µl of Opti-MEM (Gibco®) per 
manufacturer’s instructions. Cells were processed for immunofluorescence the next day.  
At 18-24 h post transfection, cells were washed 3 times with Phosphate Buffered Solution 
(PBS) and fixed with 4% para-formaldehyde (PFA) for 10 min at room temperature. Fixed 
cells were permeabilized using 0.2% Triton-X100 in PBS for 5 min. Cells were then 
washed 3 times with PBS and blocked for 1 h in 2% goat serum (in PBS). After blocking, 
 
12 
cells were incubated with primary antibody [ GFP Anitbody IgG2a (Life Technologies 
A11129, Calnexin Antibody, pAb, A01234-40 Rabbit (GenScript®), Tom20 Antibody (FL-
145): sc-11415, mouse (Santa Cruz®)] in a 1:2000 dilution with 2% goat serum in PBS for 
1 h at room temperature. Secondary antibody [1:1000 goat anti-mouse Alexa Fluor 488 
(Life Technologies®) or goat anti-rabbit Alexa flour 594 (Life Technologies®) was diluted 
in 2% goat serum in PBS and cells were incubated for 1 h at room temperature, in the dark. 
Cells were washed 3 times with PBS and incubated for 15 min with a 1:4000 dilution of 
Hoechst nuclear dye (Invitrogen®) in PBS. Cells were washed 3 times with cold PBS. 
Coverslips were mounted onto a slide using Prolong (R) Gold (Cell Signaling 
Technologies®). Coverslips were imaged using the Nikon 90i inverted fluorescence 
microscope at 40X air objective. Cells had about 70% transfection efficiency. 
Cell death assay 
Cells in 24-well plates were transfected with a total of 175 ng plasmid (35 ng tBID + 105 
ng BH3-only protein plasmid + 35 ng of BCL-xL/BCL-W empty vector) using 1.5µl of 
Lipofectamine 2000 (Invitrogen®) and 50 µl of Opti-MEM (Gibco®) according to 
manufacturer’s instructions. At 16 h post transfection, cell viability was determined using 
Trypan blue dye. Media from each well was collected, floating cells were pelleted at 800 
rpm for 7 min and the supernatant was aspirated. Adherent cells were incubated with 100 
µl of Trypsin-EDTA for 10 minutes or until all cells detached from the dish. 300µl of PBS 
was added to each well and the trypsinised cells with PBS were then added to the pelleted 
floating cells. Cells were spun down at 800 rpm for 7 minutes and cells were re-suspended 
in 100 µl of PBS. 100 µl of Trypan blue, 0.4% (Gibco®) was added to stain dead cells. 
Cells were counted within 30 s of staining using a hemocytometer and the percent total 
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cells that were dead was determined (number of Trypan blue-stained cells divided by total 
number of cells (live + dead)). 
Lysate preparation and Western Blot analysis 
Cells were seeded overnight in a 12-well plate at a density of ~8.0 X 10^5 cells per well. 
Cells were transfected with a total of 350 ng plasmid per well using Lipofectamine 2000 
(Invitrogen®) as per manufacturer’s instructions. Cells were harvested 24 h post 
transfection. 150 µl of 6x sample buffer (for 100 ml: 70 ml 0.5M Tris, pH 6.8, 10% SDS, 
5 ml BME, 30 ml glycerol, 12.5 mg Bromophenol Blue) was diluted to a 1Xworking 
concentration in RIPA buffer [10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 0.5 mM EGTA, 
1% Triton X-100, 0.1% sodium deoxycholate,0.1% SDS, 140 mM NaCl, 1mM PMSF] was 
added to each well of washed cells, and cells were scraped off. Lysates were collected in a 
1.5 ml Eppendorf tube, heated to 95°C for 5 minutes and stored at -20ºC.  
Protein lysates were resolved by SDS-PAGE on 12% gels at 110V. Proteins were 
transferred using the transblot™ system (BioRad®) to a Poly Vinyl Diflouride (PVDF) 
membrane. Membranes were blocked in TBS-T [20 mM Tris, 150 mM NaCl, pH7.6, 0.1% 
Tween®20] with 5% milk (Nestle® Carnation™) for 2 h. Membranes were incubated with 
primary antibody overnight [1:2000 GFP Antibody A6455, rabbit (Invitrogen®) ,1:10000 
GAPDH (6C5) sc-32233 (Santa Cruz®) , 1:1000 HA-probe (Y-11) sc-805, rabbit (Santa 
Cruz®), 1:1000 Actin, clone 4, mouse (Life Technologies®), washed the next morning with 
TBS-T 3 times x 5 min each, incubated with secondary antibody [ 1:10000 ECL™ Anti-
mouse IgG HRP linked whole antibody or Anti-rabbit HRP linked whole antibody (GE 
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Healthcare®)and imaged on a BioRad® Universal Hood III using Amersham™ ECL™ 





Testing for the pro-death function of candidate novel BH3-only proteins 
The eight canonical mammalian BH3-only proteins (BAD, BID, BIK, BIM, BMF, HRK, 
PUMA and NOXA) as well as the worm homolog in C. elegans, EGL-1, are all known to 
have pro-apoptotic activity and most are regulated by transcriptional and post-
transcriptional modifications (Bouillet & Strasser, 2002) as well as by anti-death members 
of the BCL-2 family (e.g. BCL-W, BCL-xL, MCL-1, BCL-2) (D. C. Huang & Strasser, 
2000).  
Mammalian expression plasmids for the top ten hits from an in silico screen for novel BH3 
motifs were provided by Dr. Abdel Aouacheria (University of Montpellier). These 
plasmids encode N-terminal GFP-fusions of the ten full-length proteins and the 
corresponding ten mutants (mut) in which the two Leu and Asp residues that define the 
BH3 motif were changed to Ala (LxxxxD/AxxxxA). These ten candidate BH3-only 
proteins are encoded by six diverse species of bacteria and four metazoans, including a sea 
anemone (Nematostella vectensis), a filarial worm (Brugia malayi), the Florida lancelet 
(Branchiostoma floridae) and the flat-worm commonly known as a blood-fluke 
(Schistosoma japonicum) (Table 1). Among these 10, three are human pathogens that cause 
schistosomiasis (Schistosoma japonicum), tuberculosis (Mycobacterium sp) and filariasis 
(Brugia malayi). To explore the possibility that these candidate BH3-only proteins might 
engage the mammalian apoptosis pathway, all 20 proteins were transiently expressed in 




Trypan blue counts show that three of the ten BH3-only candidates (three of the four 
metazoan proteins), from Nematostella vectensis, Brugia malayi and Schistosoma 
japonicum, are cytotoxic (Fig. 1). If the BH3 motif is important in promoting cell death, 
then the BH3 mutations should abolish or decrease the toxicity. Strikingly, the BH3 
mutants of all three had significantly diminished ability to cause cell death (Fig. 1), which 
could not be explained by insufficient protein expression, as the corresponding BH3 
mutants are expressed as well or better than wild type in HeLa cells (Fig. 2b, c and j). 
Similarly, failure of other BH3-only candidates to promote cell death was not due to lack 
of expression (Fig. 2a, d-i). 
Table 1. Genus and species names of Source organism encoding a candidate BH3-only 
protein, and predominant subcellular localization of wild type candidate BH3-only proteins 









Fig. 1. Cytotoxicity of a subset of candidate BH3-only proteins in mammalian 
cells Cell death determined by Trypan blue positivity was determined for HeLa 
cells transfected for 16 h with candidate BH3-only proteins and corresponding 
mutants (300ng each). Data shown are the means +/- standard deviation for 3 
independent experiments counting ~200 cells per sample. Similar results were also 





To confirm expression of all 20 N-terminal GFP-tagged candidate BH3-only proteins, we 
performed western blot analysis on HeLa cells transiently transfected with the constructs 
for WT and mut of all proteins (Fig. 2). All GFP-fusion proteins migrate within 10 kDa of 
their predicted molecular weights plus GFP (27 kDa) (Table 2). Note that the wild type 
version of the three toxic proteins from Nematostella vectensis, Brugia malayi and 
Schistosoma japonicum are expressed at much lower levels relative to their BH3 mutant 
due to loss of dying cells (Fig. 2b, 2c and 2j).  
Subcellular localization of candidate BH3-only proteins 
BCL-2 family members are often found at membranes of cell organelles, particularly the 
ER and mitochondrial membranes(Gross et al., 1999). Seven of the 10 BH3-only 
candidates, including all three of the toxic proteins from Brugia malayi, Nematostella 
vectensis and Schistosoma japonicum), four prokaryotic proteins from Mycobacterium sp, 
Brachistoma floridae and Paenibacillus sp, and Streptomyces lividans have a predicted 
transmembrane helix using several different prediction tools (see Discussion). Despite 
being non-mammalian proteins, I determined their subcellular localization in mammalian 
cells using immunofluorescence (IF) microscopy. I observed several different localization 
patterns (Table 1 and Figs. 3-5). Four candidates localized to the ER (Fig. 3a-e), the three 
toxic proteins localized to mitochondria (Fig. 5 a-c), two others localized to the nucleus 
(Fig. 4 a, b) and one exhibited both ER and nuclear localization (Fig. 3c). All transfected 
cells for each protein had the same localization (there weren’t different phenotypic 
locations for cells transfected with the same plasmid). It was surprising that none of these 
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proteins exhibited untargeted, diffuse cytoplasmic localization. However, we cannot rule 
out the possibility that the GFP tag could contribute non-specifically to nuclear localization 
by becoming partially trapped in the nucleus. The localization of BH3 mutant forms of 
candidate BH3-only proteins was unchanged except for two of the three toxic BH3-only 
candidates from Brugia malayi and Nematostella vectensis. Interestingly, these BH3 
mutations blocked localization to mitochondria (Fig. 5 a and b). Mutation of the predicted 
BH3 in Brugia malayi caused a shift in localization from the mitochondria to a more diffuse 
cytosolic localization (Fig. 5a upper and lower), raising the possibility that there is a 
mitochondrial target or receptor for the Brugia malayi BH3-only candidate. Mutation of 
the putative BH3 in the Nematostella vectensis candidate resulted in clustered aggregates 
in the cytoplasm that did not co-localize with either the mitochondrial or the ER markers, 
suggesting folding defects (Fig. 5b upper and lower panels). Although the BH3 mutations 
did not alter localization of the candidate from Schistosoma japonicum, these proteins (both 
WT and mut) caused mitochondria to be much more elongated than usual (Fig. 5c, upper 
left panel). This could potentially be due to altered mitochondrial dynamics. Although the 
WT proteins from Nematostella vectensis, Brugia malayi and Schistosoma japonicum are 
cytotoxic, the representative images show live transfected cells, which were hard to find 
since most of the transfected cells for these constructs had died and were not visible. 







Table 2. Genus and species names of Source organism encoding a candidate BH3-only 
protein with corresponding predicted size (GFP fusion protein) compared to the observed 







Fig. 2. Western blot analyses showing size of candidate BH3-only proteins. 
HeLa cells were transfected with 300ng of candidate BH3-only proteins and 
harvested 24h post transfection. Bands seen are of GFP fusion proteins that include 
a 27 kDa GFP tag, and were detected using anti-GFP antibody. Whole cell lysates 
were prepared from HeLa cells transfected with each of the 10 candidate BH3-
only proteins and 10 corresponding LxxxxD/AxxxxA BH3 mutants at 24 h post 
transfection. Representative blots from 3 independent experiments are shown, and 
the relative levels between wild type and mutant versions, as well as between 






Fig. 3. ER localization of five candidate BH3-only proteins. 
Representative immunofluorescence images of HeLa cells processed 24 h 
post transfection with wild type (WT) and mutant (mut) GFP-BH3-only 
constructs and stained with anti-GFP antibody. The ER is marked with 
antibodies to endogenous calnexin, nuclei are stained with Hoechst (blue), 
and candidate GFP-BH3-only proteins are detected with anti-GFP antibody 
(green). Markers showing co-localization with candidate BH3-only proteins 
with different cell organelles are shown  (merge). Panels a-e show co-
localization of the indicated candidate BH3-only proteins with ER marker 
calnexin. Scale bars: x-axis: 40nm y-axis: 30nm  
Positive colocalization with ER was found for the following constructs: 

















Fig. 4. Nuclear localization of two candidate BH3-only proteins. 
Representative immunofluorescence images of HeLa cells fixed and stained 24 h 
post transfection with wild type (WT) and mutant (mut) GFP-BH3-only 
constructs. The mitochondria were marked with antibodies to Tom20, nuclei is 
stained with Hoechst (blue), and candidate GFP-BH3-only proteins were 
detected with anti-GFP antibody (green). Markers showing co-localization with 
candidate BH3-only proteins with different cell organelles are shown (merge). 
Panels a,b show co-localization of the indicated candidate BH3-only proteins 
with nuclear marker. The WT protein is in the upper panel and Mut is in the 
lower panel. Hoechst. Scale bars: x-axis: 40nm y-axis: 37nm 
Positive colocalization with the nucleus was found for the following constructs: 
















Fig. 5. Mitochondrial localization of 3 candidate BH3-only proteins. 
Representative immunofluorescence images of HeLa cells fixed and stained 24 h 
post transfection with wild type (WT) and mutant (mut) GFP-BH3-only 
constructs. The mitochondria were marked with antibodies to Tom20, nuclei are 
stained with Hoechst (blue), and candidate GFP-BH3-only proteins were 
detected with anti-GFP antibody (green). Only those markers showing co-
localization with candidate BH3-only proteins with different cell organelles are 
shown (merge). Panels a-d show co-localization of the indicated candidate BH3-
only proteins with nuclear marker. The WT protein is in the upper panel and Mut 
is in the lower panel. Hoechst. Scale bars: x-axis: 40nm y-axis: 37nm. 
Positive colocalization with ER was found for the following constructs: Bm 












Potential Interaction with anti-death members of the BCL-2 family 
One way by which BH3-only proteins can trigger apoptosis is by binding to the 
hydrophobic binding groove on anti-death BCL-2 family members, thereby displacing 
either mammalian pro-death BCL-2 homologs BAX and BAK or canonical BH3-only 
proteins(Chen et al., 2005b). Liberated mammalian BH3-only proteins could subsequently 
induce BAX or BAK oligomerization to cause mitochondrial outer membrane 
permeabilization (MOMP). MOMP allows the release of pro-death factors such as 
cytochrome c to activate caspase-3-mediated apoptosis (Chen et al., 2005c). 
In vitro data indicate that peptides containing the BH3 motif of all 10 candidate BH3-only 
proteins bind to anti-apoptotic BCL-2 proteins, and can displace the binding of mammalian 
BH3 peptides (A. Aouacheria, unpublished). Evidence that these BH3 peptides are capable 
of binding in the hydrophobic groove of anti-apoptotic proteins, rather than other potential 
binding sites is based on the significantly reduced binding affinity when the BH3 LxxxxD 
is mutated to AxxxxA (A. Aouacheria, unpublished). To extend these in vitro studies, we 
tested for the ability of the three toxic BH3-only candidates to inhibit the function of anti-
apoptotic BCL-2 and BCL-W. BCL-2 and BCL-W were selected for this assay because 
they interact with the candidate BH3-only proteins (A. Aouacheria, unpublished). To test 
for a possible functional interaction between the candidate BH3-only proteins and the anti-
death BCL-2 family members, the three cytotoxic BH3-only candidates (from 
Nematostella vectensis, Brugia malayi and Schistosoma japonicum) were co-expressed 
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with BCL-xL or BCL-W in HeLa cells. Both BCL-xL and BCL-W could rescue the death 
phenotype of all three BH3-only candidates, consistent with possible direct interaction. To 
further address whether the death induced by the three toxic BH3-only candidates was due 
to caspase-dependent apoptosis, the BH3-only candidates were co-expressed with 
dominant negative caspase-9 (DNC9), which potently inhibits Bax induced cell death 
(Srinivasula et al., 1999) (Fig. 7c). Unexpectedly, dominant negative caspase-9 was 
protective only against one of the three toxic BH3-only candidates from Brugia malayi 
(Fig. 6). Despite being inhibited by anti-apoptotic BCL-2 proteins, dominant negative 
caspase-9 had no ability to rescue the death induced by expression of the other two BH3-
only candidates from Nematostella vectensis and Schistosoma japonicum, even at different 
ratios (1:1, 1:2 and 1:3 BH3-only protein: DNC9) (Data not shown). Therefore, it is 
possible that the death caused by Nematostella vectensis and Schistosoma japonicum BH3-
only candidates may not be apoptotic in nature and may follow some other death pathway. 
This hypothesis would be supported if these BH3-only candidates were able to kill 
BAX/BAK double knockout cells, while the Brugia malayi BH3 failed to kill BAX/BAK 
double knockouts, an experiment that is currently being done (in progress). 
Further evidence that cell death induced by all three toxic BH3-only candidates is 
efficiently suppressed by BCL-xL and BCL-W is evident from the Western blot analysis, 
showing rescue of protein expression of BH3-only candidates due to surviving cells (Fig. 
7a,b). The band for the WT cytotoxic proteins from Nematostella vectensis, Brugia malayi 
and Schistosoma japonicum can only be detected if co-transfected with either of the anti-
death BCL-2 family member proteins, consistent with rescue of the death phenotype (Fig. 
7a,b). Furthermore, IF imaging shows co-localization between each of the three candidate 
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BH3-only proteins and the anti-apoptotic proteins BCL-xL and BCL-W, suggesting the 
possibility of a functional interaction (Fig. 8a-c). Trypan counts confirmed rescue by anti-
death (Fig. 6a, b). 
BCL-xL and BCL-W can inhibit cell death induced by mammalian BH3-only proteins, by 
binding the BH3 motif region into their hydrophobic grooves(Chen et al., 2005a) .A similar 
mechanism could occur for the non-mammalian BH3-only candidates, preventing the anti-
apoptotic proteins from sequestering other endogenous pro-death proteins. Alternatively, 
the candidate BH3-only proteins could potentially directly activate BAX or BAK, in 
addition to, or potentially instead of binding to BCL-xL or BCL-W, analogous to direct 
activator-types of mammalian BH3-only proteins (BID, BIM and PUMA).  
The inability of dominant negative caspase-9 to rescue viability of cells expressing two of 
the three toxic proteins could suggest a different death pathway for these two candidates. 
In this case, BCL-xL and BCL-W could be protecting cells independently of their canonical 
anti-apoptotic functions (Gross & Katz, 2017; Hardwick & Soane, 2013). Alternatively, 
the failure of dominant negative caspase-9 to protect against death induced by candidate 
BH3-only proteins from Nematostella vectensis or Schistosoma japonicum could be due to 
insufficient expression of dominant negative caspase-9 as the flag-tagged dominant 
negative caspase-9 protein could not be detected on the western blots when co-transfected 
with any other protein, but could be detected in a control when transfected by itself (data 
not shown). Experiments are currently being done to tease this apart. It could be possible 
that the amount of dominant negative caspase-9 being expressed is too low to detect on a 
western blot, to account for this, experiments are being done using different ratios of BH3-
only proteins to dominant negative caspase-9. Another caveat of this experiment is that 
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dominant negative caspase-9 was unable to protect cells transfected with tBID from dying, 






Fig. 6. Interaction of cytotoxic proteins with BCL-xL and BCL-W. HeLa cells 
were transfected with the indicated plasmids and harvested 16h post transfection. 
Percent cell death was determined by trypan counts. Graph shows percent cell 
death of both cytotoxic proteins Nematostella vectensis and Schistosoma 
japonicum (WT and mut) when cells were transfected with BH3-only protein 
(88ng) (blue) BH3-only proteins and DNC9 (88ng) (green) BH3-only protein and 
BCL-xL(88ng) (red) and BH3-only protein with BCL-W(88ng) (yellow). Error 
















a )  
Fig. 7. Rescue of cell death by BCL-xL and BCL-W. HeLa cells were transfected 
with indicated plasmids and harvested 24h post transfection with 88ng of each 
plasmid. (a) Rescue of death caused by Schistosoma japonicum WT(GFP-tagged) 
by BCL-xL and BCL-W (HA-tagged) but not dominant negative caspase-9 (DNC9) 
(Flag tagged) . (b) Rescue of death caused by Nematostella vectensis WT(GFP-
tagged) by BCL-xL and BCL-W(HA-tagged) but not DNC9(flag-tagged). (c) 
Rescue of death caused by Flp-BAX(flag-tagged), a known apoptotic killer by 














Fig. 8. Localization of toxic candidate BH3-only proteins with BCL-xL 
and BCL-W. Representative immunofluorescence images of HeLa cells fixed 
and stained 24 h post transfection with wild type (WT) toxic GFP-BH3-only 
constructs and BCL-xL (lower panels) or n-terminal HA tagged BCL-W(upper 
panels). The mitochondria were marked with antibodies to Tom20, nuclei are 
stained with Hoechst (blue), and candidate GFP-BH3-only proteins were 
detected with anti-GFP antibody (green). Panel a shows localization of Sj WT 
(green) with BCL-W (upper right, red) and BCL- xL (lower right, red). Note 
that co-transfection with anti-death proteins BCL-xL and BCL-W prevent long 
mitochondrial phenotype. Panel b shows localization of Bm WT (green) with 
BCL-W (upper right, red) and BCL- xL (lower right, red). Panel c shows 
localization of Nv WT (green) with BCL-W (upper right, red) and BCL- xL 







Potential role of BH3-only candidates to act as “indirect activator” BH3-proteins 
We further addressed the possibility that these novel BH3-only candidate proteins could 
act by displacing mammalian BH3-containing pro-apoptotic proteins from the groove of 
anti-apoptotic proteins. For this, candidate BH3-only proteins were co-expressed with the 
toxic caspase-cleavage product of mammalian BH3-only protein tBID (truncated BID) to 
determine if the candidate BH3-only proteins could suppress the ability of anti-apoptotic 
BCL-xL or BCL-W to inhibit tBID-induced cell death. The co-expression of wild type or 
mutant candidate BH3-only proteins from Mycobacterium sp (Msp) has no effect on cell 
viability (Fig. 1), and when co-expressed with human tBID also had no effect on cell death 
compared to tBID alone (Fig. 10a). However, Msp reduced the ability of BCL-W, but 
apparently not BCL-xL, to suppress tBID-induced cell death by approximately 20%, 
raising the possibility that Msp may engage the BCL-W protein (Fig. 10a). However, the 
BH3 mutant version of Msp also had a similar effect, potentially suggesting non-specific 
toxicity of Msp revealed by stressing cells with tBID. An alternative potential interpretation 
is that the Msp proteins cause indirectly activate BAX or BAK. However, this seems 
unlikely cell death was not observed without the additional stress induced by tBID, as Msp 
alone is non-toxic (see Fig. 1). Results similar to Msp were also observed with other non-
toxic BH3-only candidates Gamma proteobacterium, Paenibacillus sp., Streptomyces 
lividans, Sphaerobacter thermophiles and possibly E. coli (Fig. 10d,e,g-i). In contrast, 
while the non-toxic candidate BH3-only protein Bf had no effect on the anti-apoptotic 
function of BCL-W, the wild type Bf but not its BH3 mutant completely abrogated the anti-
death function of BCL-xL in this experiment (Fig. 10f). This could suggest that the 
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mutation in its BH3 domain could have abolished its ability to bind to BCL-xL and BCL-
W, thereby rendering it unable to displace tBID from the binding groove.  
All three cytotoxic BH3-only candidate proteins from Nematostella vectensis, Brugia 
malayi and Schistosoma japonicum suppressed the anti-apoptotic functions of BCL-xL and 
BCL-W (Fig. 10b,c,j), consistent with the ability of BCL-xL and BCL-W to suppress cell 
death induced by these three proteins (see Fig. 6). While the BH3 mutant versions of these 
three proteins were somewhat less effective. Results from this experiment can be 
interpreted in many ways, to confirm the possible role of these candidate BH3-only 
proteins in indirect activation of BAK/BAX, the next step would be to test them in BAK-/-

















Fig. 9. tBID death assay. tBID is a cytotoxic protein. Cells transfected by tBID 
itself should have considerable death. Co-transfection with an anti-death BCL-
2 family member should rescue this cell death by binding tBID. If a BH3-only 
protein with some known affinity for the anti-death proteins is added to cells, 
competitive binding of this protein to the anti-death protein should liberate tBID, 




   
 
  
Fig. 10. tBID vs candidate BH3-only proteins. Representative experiment where 
HeLa cells were transfected with indicated plasmids and harvested 24h post 
transfection. Y-axis represents cell death in terms of percent of trypan positive cell 









BH3 mimetics can be used against cancer, and have the potential to be used for auto-
immune diseases and infectious diseases like schistosomiases, the problem is being able to 
discover candidate novel BH3-only proteins in the proteome in the absence of a signature 
sequence with which to search the preoteome, in order to find such targets. Our list of BH3-
only proteins that were found using an algorithm implemented by Dr. Abdel Aouacheria 
(unpublished) are surprisingly all from non-mammalian sources. These sources include 
bacteria, filarial worms and even parasites like schistosomes (Table 1). The BCL-2 family 
proteins are not known to exist in these species other than in Schistosoma japonicum (Lee 
et al., 2014) but based on their sequences, all the 10 candidate proteins behaved similarly 
to ‘real BH3-only proteins’ when put through different binding assays and tests (Abdel 
Aouacheria, data unpublished). In our hands, all ten proteins and their mutants were 
expressed, although the bands for three of the killer WT proteins could not be detected 
(Fig, 2b, c and j), apparently not due to a lower expression of these proteins but due to their 
cytotoxic activity. The more minor differences in expression in the other pairs of non-toxic 
proteins could be due to a difference in transcription level or maybe even due to a difference 
in number of transfected cells, since the immunofluorescence images do not show a 
noticeable difference in intensity of GFP signal between different proteins (Figs. 3-5). 
All of the candidate BH3-only proteins seemed to go to an intra-cellular membrane, except 
the BH3 mutants from Brugia malayi and Nematostella vectensis. However, since the 
constructs are N-terminally GFP tagged, it is possible that the tag can interfere with 
localization of the protein, for example, it can get retained in the nucleus. On further 
analyzing the sequence of BH3-only proteins using different online tools to predict the 
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presence of transmembrane domains, only seven out of the 10 had predicted 
transmembrane segments, however this prediction varies depending on which tool was 
used, since different tools use different algorithms and prediction methods. Only three 
proteins were consistently predicted to contain transmembrane segments by all three tools: 
Mycobacterium sp. and the toxic proteins from Schistosoma japonicum and Neamtostella 
vectensis. Using TMHMM, transmembrane segments were predicted in the proteins from 
Mycobacterium sp and Branchistoma floridae, even though their probability score was low. 
Using another tool, Octopus, transmembrane helices were predicted for the candidates from 
Paenibacillus sp, Nematostella vectensis and Streptomyces lividans. Using another tool, 
Phobius, transmembrane helices were predicted in BH3-only candidates from 
Mycobacterium sp. and Branchistoma floridae. All three tools predicted a C-terminal 
transmembrane helix in candidate protein from Schistosoma japonicum with high 
probability of occurrence. It should also be kept in mind that these tools are only prediction 
tools. There could be another way that these proteins are anchoring themselves onto 
membranes, possibly via lipid modifications or other mechanisms. It should be noted that 
the amino acid sequence of both the WT and Mut proteins from Brugia malayi have been 
modified on the Uniprot database after the plasmids for these constructs were made. After 
speaking with one of the curators from the database website, I learned that 43 amino acids 
were previously left out on the C-terminal of the protein. Future work for this project 
includes making new constructs with the complete updated sequence and testing for any 
difference in function and localization. Candidate BH3-only proteins from Paenibacillus 
sp. also have a predicted N-terminal signal peptide, however since these proteins are N-
terminally GFP tagged, this could hinder with the function of the protein’s signal peptide. 
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This construct needs to be cloned into a C-terminally tagged vector to study to function of 
its signal peptide.  
Although all cells transfected with each of the three cytotoxic candidate BH3-only proteins 
from Nematostella vectensis, Brugia malayi and Schistosoma japonicum could be rescued 
by co-transfecting the cells with either BCL-xL or BCL-W (Fig. 6), two out of the three 
toxic candidate BH3-only proteins from Nematostella vectensis and Schistosoma 
japonicum could not be rescued by dominant negative caspase-9. A caveat of this 
experiment could be that we are not expressing enough dominant negative caspase-9 
protein (since it can’t be seen on a blot when co-transfected with these proteins either), a 
future experiment could be do increase the ratio of dominant negative caspase-9 as 
compared to the BH3-only protein. Another possibility can be that the candidate proteins 
from these two organisms are such hyper active killers that dominant negative caspase-9 is 
too slow in comparison to rescue cells from dying. To test this hypothesis, we would have 
to transfect dominant negative caspase-9 before transfecting either of the two killer 
proteins. To test whether all three cytotoxic proteins kill in a BAK/BAX dependent manner, 
future work is being done to express these proteins in BAK-/-/BAX-/- double knockout 
MEFs. If death induced by the candidate BH3-only proteins from Schistosom japonicum 
and Nematostella vectensis is indeed non-apoptotic in nature, future work would include 
testing for different death pathways that could be initiated by candidate BH3-only proteins 
from Nematostella vectensis and Schistosoma japonicum. Some of the ways to test different 
death pathways could be to use inhibitors of different pathways for example, an iron 
chelator to test for ferroptosis, necrostatin to check for necrosis as well as spautin to check 
for autophagic cell death. Future work could also include testing the impact of 
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mitochondrial integrity, especially for candidate proteins from Schistosoma japonicum that 
causes elongation of mitochondria (Fig. 5 c) by using a Drp1 inhibitor to check for fission 
defects, test for cytochrome release etc. 
The ability of these proteins to interact with tBID, a pro-death protein that it cytotoxic by 
itself and that binds to the hydrophobic grooves of BCL-xL and BCL-W was also tested 
(Fig. 10). Even though different proteins showed different results based on their own 
cytotoxic abilities, their interactions with BCL-xL and BCL-W as well as their functional 
interaction with tBID, it could be possible that a few of the proteins that caused an increase 
in cell death even in the presence of an anti-apoptotic protein like BCL-W, which when 
transfected by itself rescues tBID associated cell death (Fig. 10 a-j) could be doing so by 
indirectly activating BAX/BAK by binding to these anti-death proteins and neutralizing 
them. This would lead to a release in tBID which would explain the death even in the 
presence of anti-death proteins. WT proteins from Mycobacterium sp., Nematostella 
vectensis, Brugia Malayi, Sphaerobacter thermophiles and Schistosoma japonicum were 
able to cause an increased cell death even in the presence of BCL-W (Fig. 10). However, 
proteins from Nematostella vectensis, Brugia Malayi and Schistosoma japonicum are toxic 
themselves and this could explain the increased cytotoxicity even in the presence of BCL-
W. Proteins from E.coli show similar trends to the empty vector controls (Fig. 10d) 
suggesting that it may not be able to displace tBID from the binding groove and in-turn 
may not be able to indirectly activate BAK/BAX. Gamma proteobacterium candidate 
proteins showed a protection with BCL-W but not BCL-xL, similar results were seen for 
proteins from Streptomyces lividans (Fig. 10e,h) whereas the mutant didn’t seem to show 
any protection at all, even in the presence of anti-death proteins (Fig. 10e), a similar result 
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was seen for proteins from Sphaerobacter thermophiles (Fig. 10 g) suggesting that the 
mutant could have displaced tBID from the binding groove, leading to liberation of tBID 
and killing of cells. WT proteins from Branchistoma floridae and Paenibacillus sp. show 
similar results. While protection is seen in the presence of BCL-W, BCL-xL fails to protect 
cells from dying (Fig. 10 f,i). Both BCL-xL and BCL-W fail to protect cells in the presence 
of tBID and WT cytotoxic protein from Schistosoma japonicum (Fig. 10j). The mutant 
however, which by itself is toxic, but not as toxic as its wild type counterpart, seems to 
show protection with BCL-W (Fig, 10j).  
To fully understand and appreciate the functions of these candidate novel BH3-only 
proteins, we need to understand more about their day jobs and non-death functions(Gross 
& Katz, 2017).  
However, if this algorithm can pull out real BH3-only proteins from the proteome in 
organisms that before this have no studied BCL-2 proteins, that would open a whole new 
are in BH3 mimetic development. We could now use BH3 mimetics not only to treat cancer 
but also bacterial and parasitic infections, which could be the need of the hour given 
emerging antibiotic resistance in these organisms. Another idea is that the discovery of 
genuine BH3 motifs in proteins from non-metazoan species poses the question of the 
identity, structure and function of their endogenous receptors. These natural receptors 
might also have homologs in metazoan species, which could interact with SLiMs or other 
motifs. If so, the interaction between BH3 motifs and Bcl-2 family proteins might represent 
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